Investor AB acquires 21.4% stake in Biovitrum - MarketLine Financial Deals

Investor AB acquires 21.4% stake in Biovitrum

Investor AB acquires 21.4% stake in Biovitrum - MarketLine Financial Deals
Investor AB acquires 21.4% stake in Biovitrum
Published Mar 27, 2009
3 pages — Published Mar 27, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Investor AB, a private equity firm, has acquired a 21.4% stake and 21.5% of the votes in Biovitrum AB, a pharmaceutical company that markets a range of specialist pharmaceuticals.

  
Source:
Document ID
MA02802_090331
Country
Ticker
BVT=SE
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Investor AB acquires 21.4% stake in Biovitrum" Mar 27, 2009. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Investor-AB-acquires-21-4-stake-in-Biovitrum-2052-2778>
  
APA:
MarketLine Financial Deals. (2009). Investor AB acquires 21.4% stake in Biovitrum Mar 27, 2009. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Investor-AB-acquires-21-4-stake-in-Biovitrum-2052-2778>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.